212 related items for PubMed ID: 15331936
1. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
Fu LS, Shien CY, Chi CS.
Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936
[Abstract] [Full Text] [Related]
2. Levamisole in steroid-sensitive nephrotic syndrome children with steroid-dependency and/or frequent relapses.
Fu LS, Chi CS.
Acta Paediatr Taiwan; 2000; 41(2):80-4. PubMed ID: 10927944
[Abstract] [Full Text] [Related]
3. Levamisole treatment in steroid sensitive nephrotic syndrome.
Alshaya HO, Kari JA.
Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722
[Abstract] [Full Text] [Related]
4. Effect of levamisole in steroid-dependent nephrotic syndrome.
Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
[Abstract] [Full Text] [Related]
5. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY, Wu CY, Tsai IJ, Tsau YK.
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[Abstract] [Full Text] [Related]
6. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
[Abstract] [Full Text] [Related]
7. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
Abeyagunawardena AS, Karunadasa U, Jayaweera H, Thalgahagoda S, Tennakoon S, Abeyagunawardena S.
Pediatr Nephrol; 2017 Aug 27; 32(8):1363-1367. PubMed ID: 28299461
[Abstract] [Full Text] [Related]
8. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
Basu B, Babu BG, Mahapatra TK.
Clin Exp Nephrol; 2017 Feb 27; 21(1):143-151. PubMed ID: 27108294
[Abstract] [Full Text] [Related]
9. [Immunologic state and effect of long-term levamisole therapy on selected immunologic parameters in children with steroid sensitive nephrotic syndrome during remission].
Prandota J, Jankowski A, Szozda A.
Pol Tyg Lek; 2017 Feb 27; 48(20-22):455-9. PubMed ID: 8170809
[Abstract] [Full Text] [Related]
10. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS, Hindmarsh P, Trompeter RS.
Arch Dis Child; 2007 Jul 27; 92(7):585-8. PubMed ID: 17284479
[Abstract] [Full Text] [Related]
11. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
Pediatr Nephrol; 2002 May 27; 17(5):355-8. PubMed ID: 12042893
[Abstract] [Full Text] [Related]
12. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A, Hari P, Moudgil A, Jordan SC.
Am J Kidney Dis; 2003 Dec 27; 42(6):1114-20. PubMed ID: 14655181
[Abstract] [Full Text] [Related]
13. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
Hafeez F, Ahmed TM, Samina U.
J Coll Physicians Surg Pak; 2006 Jan 27; 16(1):35-7. PubMed ID: 16441986
[Abstract] [Full Text] [Related]
14. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
Alsaran K, Grisaru S, Stephens D, Arbus G.
Clin Nephrol; 2001 Oct 27; 56(4):289-94. PubMed ID: 11680658
[Abstract] [Full Text] [Related]
15. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP, Thakur N, Mishra RN, Prasad R.
J Nephrol; 2012 Oct 27; 25(3):394-400. PubMed ID: 21928226
[Abstract] [Full Text] [Related]
16. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
Sinha A, Devi KG, Kalra S, Mani K, Hari P, Bagga A.
Kidney Int; 2024 May 27; 105(5):1113-1123. PubMed ID: 38360110
[Abstract] [Full Text] [Related]
17. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, Dötsch J.
Nephrol Dial Transplant; 2012 May 27; 27(5):1910-5. PubMed ID: 22076431
[Abstract] [Full Text] [Related]
18. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
Raja K, Parikh A, Webb H, Hothi D.
Pediatr Nephrol; 2017 Jan 27; 32(1):99-105. PubMed ID: 27677978
[Abstract] [Full Text] [Related]
19. Levamisole in children's idiopathic nephrotic syndrome.
La Manna A, Polito C, Del Gado R, Foglia AC.
Child Nephrol Urol; 2017 Jan 27; 9(4):200-2. PubMed ID: 3255483
[Abstract] [Full Text] [Related]
20. Difficult-to-treat nephrotic syndrome: management and outcome.
Sumboonnanonda A, Chongchate N, Suntornpoch V, Pattaragarn A, Supavekin S.
J Med Assoc Thai; 2005 Nov 27; 88 Suppl 8():S142-8. PubMed ID: 16856434
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
